Editorial ArticleDrug Discovery & Development
How single-cell metabolomics and AI could transform toxicity prediction and drug discovery
DeepCyte CEO Theodore Alexandrov explains how metabolomics and AI are advancing predictive toxicology, drug safety, and digital cell models



















